She’d acquired HIV as a college student in the 1980s, she told the audience at an infectious disease conference in San ...

Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and the risk ...

Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...

Omeros has announced that the activation of clinical trial sites for patient enrolment is now in progress for its Phase III ...

Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening ...

When much of the world was first introduced to physical distancing when COVID broke out in 2020, gay San Francisco resident ...

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

Over the past decades, bronchiectasis has been neglected, despite the global burden.1,2 To date, better diagnosis due to easy ...

Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...

Tharimmune (THAR) announced preclinical results for its novel oral antibody, TH023. In a murine model, a proprietary protease enzyme stabilized ...